IRIS
GITTO, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.517
EU - Europa 6.140
AS - Asia 5.378
SA - Sud America 2.048
AF - Africa 163
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 32.264
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.328
SG - Singapore 2.249
BR - Brasile 1.818
IE - Irlanda 1.566
SE - Svezia 1.333
CN - Cina 1.288
IT - Italia 616
UA - Ucraina 605
VN - Vietnam 592
HK - Hong Kong 580
DE - Germania 544
GB - Regno Unito 345
FI - Finlandia 313
RU - Federazione Russa 250
IN - India 247
FR - Francia 139
AR - Argentina 90
CA - Canada 89
PL - Polonia 66
CZ - Repubblica Ceca 61
MX - Messico 60
BE - Belgio 57
BD - Bangladesh 52
JP - Giappone 52
AT - Austria 51
NL - Olanda 49
IQ - Iraq 47
ZA - Sudafrica 46
TR - Turchia 41
MA - Marocco 39
EC - Ecuador 37
UZ - Uzbekistan 33
CI - Costa d'Avorio 32
ES - Italia 28
ID - Indonesia 19
CO - Colombia 18
CL - Cile 17
PK - Pakistan 16
PY - Paraguay 16
UY - Uruguay 16
VE - Venezuela 16
IR - Iran 15
GR - Grecia 14
JO - Giordania 14
EG - Egitto 13
AZ - Azerbaigian 12
LT - Lituania 12
LV - Lettonia 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
NO - Norvegia 10
OM - Oman 10
DO - Repubblica Dominicana 9
KE - Kenya 9
KZ - Kazakistan 9
NP - Nepal 9
AL - Albania 8
IL - Israele 8
RO - Romania 8
BO - Bolivia 7
KG - Kirghizistan 7
MY - Malesia 7
NZ - Nuova Zelanda 7
SK - Slovacchia (Repubblica Slovacca) 7
AM - Armenia 6
HN - Honduras 6
PA - Panama 6
PT - Portogallo 6
SA - Arabia Saudita 6
CH - Svizzera 5
CR - Costa Rica 5
DZ - Algeria 5
JM - Giamaica 5
KR - Corea 5
LB - Libano 5
LK - Sri Lanka 5
MD - Moldavia 5
PS - Palestinian Territory 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
IS - Islanda 4
LU - Lussemburgo 4
NI - Nicaragua 4
PH - Filippine 4
RS - Serbia 4
SN - Senegal 4
AU - Australia 3
CY - Cipro 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CG - Congo 2
Totale 32.238
Salva come PNG Salva come JPEG
Città #
Dallas 10.061
Dublin 1.564
Chandler 1.189
Jacksonville 1.137
Ashburn 1.100
Singapore 1.069
Nyköping 862
Beijing 599
Hong Kong 576
Dong Ket 358
Los Angeles 290
Princeton 254
Dearborn 244
Cambridge 215
Medford 210
Des Moines 187
Messina 177
The Dalles 165
Ann Arbor 158
Boardman 150
Hyderabad 125
Buffalo 116
São Paulo 114
Munich 109
New York 101
Ho Chi Minh City 93
Woodbridge 89
Lancaster 86
Wilmington 69
Pune 63
Moscow 58
Redondo Beach 55
Brussels 53
San Mateo 53
Hanoi 52
Tianjin 52
Turku 52
Belo Horizonte 50
Jinan 50
Warsaw 50
Seattle 49
Brooklyn 47
Rio de Janeiro 46
Brno 43
Shenyang 41
Vienna 40
Tokyo 39
Milan 36
Catania 35
Brasília 34
Houston 33
Johannesburg 33
Tashkent 33
Abidjan 32
Denver 32
London 32
Santa Clara 32
Council Bluffs 30
Frankfurt am Main 30
Nanjing 30
Rome 30
Atlanta 29
Chicago 29
Haikou 28
Helsinki 28
Montreal 28
Phoenix 27
Stockholm 27
Amsterdam 26
Curitiba 26
Orem 26
Washington 25
Porto Alegre 23
Baghdad 22
Nuremberg 22
Taizhou 21
Chennai 20
Hangzhou 20
Poplar 20
Düsseldorf 19
Fuzhou 19
Lappeenranta 19
Ningbo 19
Toronto 19
Boston 18
Ottawa 18
Zhengzhou 18
Francofonte 17
Goiânia 17
Nanchang 17
Ribeirão Preto 17
Fortaleza 16
Guangzhou 16
Guayaquil 16
Hebei 16
Manchester 16
Turin 16
Augusta 15
Betim 15
Campinas 15
Totale 23.617
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.672
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.644
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 233
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 214
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 214
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 208
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 181
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 161
4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one 154
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 154
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 153
AMPA receptor antagonists: Synthesis and pharmacological evaluation 152
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 148
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 142
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 140
Anticonvulsant agent: enhancement of physicochemical properties 139
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 138
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 136
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 135
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 135
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 134
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 129
5-Phenyl-9H-1,3-dioxolo[4,5-h][2,3]-benzodiazepin-8(7H)-one 128
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 127
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 126
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 125
Design and synthesis of acetylcholinesterase inhibitors 124
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 124
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 124
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 121
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 121
2,3-Benzodiazepines as potential AMPA receptors antagonists 119
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 119
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 119
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 117
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 117
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 116
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 116
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 115
Antiretroviral strategy using multi-target agents 115
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 115
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 114
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 114
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 113
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 113
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 113
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 113
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 113
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinase 111
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 111
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 111
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 111
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 110
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 109
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 109
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 108
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 108
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 107
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 107
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 106
Annelated 1,5-benzothiazepines 106
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 105
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 105
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 105
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 105
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS 105
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 104
Design, synthesis and in vitro evaluation of 4-fluorobenzyl- and 4-hydroxyphenyl-based compounds targeting tyrosinases 104
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 103
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 103
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 103
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 102
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 102
Proprietà elettroniche di derivati tieno- e benzo-diazepinici 101
Binding modes of noncompetitive AMPA antagonists: a computational approach 101
Exploring the MUC1/CIN85 interaction to investigate a small library of peptide inhibitors as potential anti-metastatic agents 101
Analysis of structure-activity relationships in a series of 4-(1-piperazinyl)phenol-based derivatives as competitive inhibitors of Tyrosinase 101
Le acque potabili in provincia di Messina - approvvigionamento e distribuzione 100
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 100
ELECTRONIC-PROPERTIES OF THIENODIAZEPINE AND BENZODIAZEPINE DERIVATIVES 99
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 99
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 98
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 98
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 97
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 97
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 97
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 96
Searching for alpha-syn inhibitors to fight Parkinson’s disease 96
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 95
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 94
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 94
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 94
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 94
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 94
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 94
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 93
Exploring the chemical space of 3-chloro-4-fluorophenyl-based compounds as tyrosinase inhibitors 92
High-performance liquid chromatographic determination of new 2,3-benzodiazepines 92
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 92
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 92
Totale 20.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.249 0 0 0 0 0 175 15 185 49 211 162 452
2021/20221.596 38 201 32 66 64 30 135 59 38 79 320 534
2022/20234.717 368 418 208 423 348 464 94 242 1.912 16 168 56
2023/20241.343 94 189 81 253 107 235 20 64 5 155 23 117
2024/20255.302 83 103 124 311 248 150 149 1.203 1.297 318 493 823
2025/202614.567 733 3.519 7.511 1.313 1.281 210 0 0 0 0 0 0
Totale 32.615